We are live on
!
Find out more
NMC
NEA Management Company Portfolio holdings
AUM
$1.76B
1-Year Est. Return
223.33%
This Fund
S&P 500
This Quarter
Est. Return
+17.55%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$1.45B
AUM Growth
-$333M
(-19%)
Cap. Flow
-$189M
Cap. Flow
% of AUM
-13.09%
Top 10 Holdings %
Top 10 Hldgs %
62.93%
Holding
58
New
1
Increased
5
Reduced
10
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Geron
GERN
|
+$14.3M |
| 2 |
UTRS
Minerva Surgical, Inc. Common Stock
UTRS
|
+$7.52M |
| 3 |
ADXN
Addex Therapeutics
ADXN
|
+$5.77M |
| 4 |
Senti Biosciences Holdings
SNTI
|
+$427K |
| 5 |
Wheels Up
UP
|
+$52.3K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
OYST
Oyster Point Pharma, Inc. Common Stock
OYST
|
+$66.2M |
| 2 |
Rhythm Pharmaceuticals
RYTM
|
+$50.2M |
| 3 |
Coursera
COUR
|
+$38.8M |
| 4 |
Cloudflare
NET
|
+$34.2M |
| 5 |
CBIO
Crescent Biopharma
CBIO
|
+$9.46M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 67.32% |
| 2 | Technology | 13.44% |
| 3 | Consumer Staples | 10.25% |
| 4 | Industrials | 7.8% |
| 5 | Communication Services | 1.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Coursera
COUR
$1.77B
| $148M | 10.25% |
12,867,769
-3,000,000
| -19% | -$38.8M |
|
|
ACLX
2
DELISTED
Arcellx
ACLX
| $146M | 10.11% |
4,745,262
| – | – |
|
|
VRNA
3
DELISTED
Verona Pharma
VRNA
| $112M | 7.75% |
5,584,753
| – | – |
|
4
Mirum Pharmaceuticals
MIRM
$6.56B
| $101M | 6.95% |
4,186,243
| – | – |
|
5
IonQ
IONQ
$11.9B
| $89.9M | 6.21% |
14,614,829
| – | – |
|
|
6
Cloudflare
NET
$96B
| $77M | 5.32% |
1,249,215
-624,608
| -33% | -$34.2M |
|
7
CRISPR Therapeutics
CRSP
$4.69B
| $71.8M | 4.96% |
1,587,854
| – | – |
|
8
Monte Rosa Therapeutics
GLUE
$1.82B
| $59.9M | 4.14% |
7,692,298
| – | – |
|
|
BGRY
9
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| $52.7M | 3.64% |
38,183,023
| – | – |
|
|
10
Rhythm Pharmaceuticals
RYTM
$7.31B
| $51.9M | 3.59% |
2,909,956
-2,000,000
| -41% | -$50.2M |
|
|
NEUE
11
DELISTED
NeueHealth
NEUE
| $48.1M | 3.32% |
2,726,920
| – | – |
|
12
Savara
SVRA
$1.08B
| $47.1M | 3.25% |
24,137,931
| – | – |
|
|
13
Geron
GERN
$898M
| $46.3M | 3.2% |
21,347,838
+5,029,157
| +31% | +$14.3M |
|
14
Aurinia Pharmaceuticals
AUPH
$1.95B
| $43.5M | 3.01% |
3,969,834
| – | – |
|
|
DM
15
DELISTED
Desktop Metal, Inc.
DM
| $33.1M | 2.29% |
1,439,893
| – | – |
|
|
OKUR
16
OnKure Therapeutics
OKUR
$160M
| $28.6M | 1.98% |
478,549
| – | – |
|
|
ALLK
17
DELISTED
Allakos
ALLK
| $27.4M | 1.89% |
6,147,260
| – | – |
|
|
ZFOX
18
DELISTED
ZeroFox Holdings, Inc. Common Stock
ZFOX
| $26.4M | 1.82% |
18,068,513
| – | – |
|
19
CVRx
CVRX
$131M
| $22.1M | 1.53% |
2,370,542
| – | – |
|
20
Trevi Therapeutics
TRVI
$2.57B
| $21M | 1.45% |
11,370,376
-2,798
| -0% | -$6.33K |
|
|
ADAP
21
DELISTED
Adaptimmune Therapeutics
ADAP
| $18.6M | 1.29% |
17,079,779
| – | – |
|
22
BuzzFeed
BZFD
$99M
| $17.3M | 1.2% |
3,833,473
| – | – |
|
23
NextNav
NN
$1.79B
| $16.6M | 1.15% |
8,189,156
| – | – |
|
|
CTIC
24
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $15.5M | 1.07% |
3,685,683
| – | – |
|
|
INZY
25
DELISTED
Inozyme Pharma
INZY
| $14M | 0.97% |
2,437,689
| – | – |
|
Similar funds
NM
SLF
CCIA
SW
CGH
PWP
CIP
KOCAA
NEA Management Company's Q1 2023 Portfolio in Review
As of Q1 2023, NEA Management Company held 58 positions worth $1.45B, down 19% from $1.78B the previous quarter. Its ten largest holdings account for 63% of the portfolio.
NEA Management Company withdrew a net $189M in Q1 2023, closing 5 positions and reducing 10 holdings. Its most notable exit was Oyster Point Pharma, Inc. Common Stock, an estimated $66.2M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 67% of assets, down from 71% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, NEA Management Company opened a new position in Palo Alto Networks worth $15.6K.
- NEA Management Company's largest Q1 2023 buy was Palo Alto Networks: 156 shares worth $15.6K.
- NEA Management Company added most to Geron in Q1 2023, an estimated $14.3M increase.
- NEA Management Company's biggest Q1 2023 reduction was Rhythm Pharmaceuticals, cutting an estimated $50.2M.
- NEA Management Company fully exited Oyster Point Pharma, Inc. Common Stock in Q1 2023, selling an estimated $66.2M.
- NEA Management Company's ten largest holdings make up 63% of its $1.45B portfolio in Q1 2023.
- NEA Management Company opened 1 new position and closed 5 in Q1 2023.
- NEA Management Company's portfolio value fell 19% quarter-over-quarter to $1.45B.
Based on NEA Management Company's 13F filing for Q1 2023, filed 15 May 2023.